Calmark Sweden Past Earnings Performance

Past criteria checks 0/6

Calmark Sweden's earnings have been declining at an average annual rate of -39.3%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been declining at an average rate of 31.7% per year.

Key information

-39.3%

Earnings growth rate

-17.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate-31.7%
Return on equity-54.1%
Net Margin-16,348.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Calmark Sweden makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9C7 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-22170
30 Sep 230-32200
30 Jun 230-44220
31 Mar 230-47240
31 Dec 220-48250
30 Sep 221-41250
30 Jun 223-29250
31 Mar 226-27270
31 Dec 219-22280
30 Sep 2110-18280
30 Jun 2111-15250
31 Mar 219-12210
31 Dec 2010-11200
30 Sep 2017-9260
30 Jun 2015-9240
31 Mar 2012-9210
31 Dec 1911-8190
30 Sep 196-7130
30 Jun 195-7120
31 Mar 197-6130
31 Dec 185-5100
30 Sep 183-470
30 Jun 183-460
31 Mar 182-350
31 Dec 172-350
31 Dec 160-220

Quality Earnings: 9C7 is currently unprofitable.

Growing Profit Margin: 9C7 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9C7 is unprofitable, and losses have increased over the past 5 years at a rate of 39.3% per year.

Accelerating Growth: Unable to compare 9C7's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9C7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: 9C7 has a negative Return on Equity (-54.09%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.